Study of Becotatug Vedotin Added to Standard Treatment for Advanced Bile Duct Cancer With EGFR Mutations

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This article has no abstract
Epistemonikos ID: 66fbefa19fcb7793f18c72d0c65103d7470b7bad
First added on: May 20, 2026